Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

NCT00412984 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20976

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Atrial Flutter

Interventions

DRUG: warfarin
DRUG: apixaban

Sponsor

Bristol-Myers Squibb